Valiant Laboratories Limited has informed the Exchange regarding Change in Director(s) of the company.
VALIANTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
At a board meeting held on August 8, 2025, Valiant Laboratories approved two key items. First, it appointed M/s. Mehta & Mehta, a Mumbai-based firm of practicing company secretaries with over 25 years of experience, as its Secretarial Auditor for an initial 5-year term covering FY 2025-26 to FY 2029-30, subject to shareholder approval at the upcoming AGM. Second, the board approved the re-designation of Mr. Paresh Shah from Executive Director to Whole-time Director, also classifying him as a Key Managerial Personnel (KMP), for a 5-year term from September 25, 2025 to September 24, 2030. Mr. Shah is a chemical engineer with 35+ years of industry experience and oversees factory operations, legal matters, and financial activities such as budgeting and project financing. Both decisions require shareholder ratification at the ensuing AGM.
This is a routine governance update with no material financial impact. The appointment of an experienced secretarial auditor strengthens compliance oversight, while the elevation of an existing director to whole-time director status signals continuity in operations and management. Stock price is unlikely to be materially affected.